Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksATK.L Regulatory News (ATK)

  • There is currently no data for ATK

Form 8.3 - WS ATKINS PLC

25 May 2017 15:08

FORM 8.5 (EPT/NON-RI)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (“RI”) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose WS ATKINS PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 24 May 2017
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 0.5p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 1,163,333 1.16% 1,003,716 1.00%
(2) Cash-settled derivatives:
63,359 0.06% 995,972 0.99%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 1,226,692 1.23% 1,999,688 2.00%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
0.5p ordinary Purchase 32 20.8593 GBP
0.5p ordinary Purchase 32 20.8600 GBP
0.5p ordinary Purchase 37 20.8900 GBP
0.5p ordinary Purchase 70 20.8814 GBP
0.5p ordinary Purchase 96 20.8800 GBP
0.5p ordinary Purchase 130 20.9000 GBP
0.5p ordinary Purchase 150 20.8836 GBP
0.5p ordinary Purchase 177 20.8846 GBP
0.5p ordinary Purchase 414 20.8590 GBP
0.5p ordinary Purchase 473 20.8700 GBP
0.5p ordinary Purchase 1,031 20.8692 GBP
0.5p ordinary Purchase 1,339 20.8979 GBP
0.5p ordinary Purchase 1,477 20.8863 GBP
0.5p ordinary Purchase 3,323 20.8925 GBP
0.5p ordinary Purchase 14,117 20.8737 GBP
0.5p ordinary Sale 74 20.9087 GBP
0.5p ordinary Sale 83 20.8838 GBP
0.5p ordinary Sale 96 20.8800 GBP
0.5p ordinary Sale 130 20.9000 GBP
0.5p ordinary Sale 186 20.8737 GBP
0.5p ordinary Sale 255 20.8698 GBP
0.5p ordinary Sale 327 20.8848 GBP
0.5p ordinary Sale 473 20.8700 GBP
0.5p ordinary Sale 678 20.8600 GBP
0.5p ordinary Sale 737 20.8900 GBP
0.5p ordinary Sale 1,960 20.8753 GBP
0.5p ordinary Sale 4,720 20.8795 GBP
0.5p ordinary Sale 8,440 20.8799 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
0.5p ordinary CFD Long 74 20.9087 GBP
0.5p ordinary SWAP Long 916 20.8835 GBP
0.5p ordinary SWAP Long 1,038 20.8842 GBP
0.5p ordinary SWAP Long 12,244 20.8795 GBP
0.5p ordinary CFD Short 70 20.8814 GBP
0.5p ordinary SWAP Short 127 20.8602 GBP
0.5p ordinary SWAP Short 1,268 20.8849 GBP
0.5p ordinary CFD Short 1,339 20.8979 GBP
0.5p ordinary CFD Short 2,786 20.8948 GBP
0.5p ordinary CFD Short 3,039 20.8869 GBP
0.5p ordinary CFD Short 3,323 20.8925 GBP
0.5p ordinary SWAP Short 7,197 20.8600 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 25 May 2017
Contact name: Femi Badmos
Telephone number: 020 3555 1125

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170525005638/en/

Copyright Business Wire 2017

Date   Source Headline
4th Apr 20173:06 pmRNSForm 8.3 - [WS Atkins plc]
4th Apr 20172:57 pmRNSForm 8.3 - Atkins (WS)
4th Apr 20172:56 pmRNSForm 8.3 - WS Atkins Plc
4th Apr 20172:32 pmRNSForm 8.3 - ATKINS (WS) PLC
4th Apr 20171:17 pmRNSForm 8.3 - WS Atkins PLC
4th Apr 201712:39 pmRNSForm 8.3 - WS Atkins plc
4th Apr 201712:39 pmPRNForm 8.3 - WS Atkins PLC
4th Apr 201711:53 amRNSForm 8.3 -Atkins (WS) Plc
4th Apr 201711:40 amRNSForm 8.5 (EPT/RI) - WS Atkins
4th Apr 201710:59 amRNSForm 8.3 - WS Atkins PLC
4th Apr 201710:34 amRNSForm 8.5 (EPT/RI) - Atkins (WS) Plc
3rd Apr 20172:55 pmRNSForm 8.3 - WS Atkins Plc
3rd Apr 20171:18 pmRNSStatement re Possible Offer
28th Mar 20177:00 amRNSAnalyst Presentation
17th Mar 20177:00 amRNSDirector/PDMR Shareholding
16th Feb 20174:51 pmRNSDirector/PDMR Shareholding
8th Feb 20177:00 amRNSTrading Statement
20th Jan 20174:23 pmRNSHolding(s) in Company
18th Jan 20173:06 pmRNSHolding(s) in Company
18th Jan 20172:58 pmRNSDirector/PDMR Shareholding
12th Jan 20176:04 pmRNSDirector/PDMR Shareholding
19th Dec 20163:58 pmRNSDirector/PDMR Shareholding
24th Nov 20165:10 pmRNSDirector/PDMR Shareholding
24th Nov 20165:02 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:06 pmRNSDirector/PDMR Shareholding
21st Nov 20164:26 pmRNSDirector/PDMR Shareholding
17th Nov 20164:48 pmRNSDirector/PDMR Shareholding
17th Nov 20167:00 amRNSHalf-year Report
14th Nov 20167:00 amRNSDirectorate Change
19th Oct 20165:56 pmRNSDirector/PDMR Shareholding
3rd Oct 20164:06 pmRNSHolding(s) in Company
30th Sep 20167:00 amRNSCapital Markets event
29th Sep 20167:00 amRNSTrading Statement
28th Sep 20163:38 pmRNSDirector/PDMR Shareholding
19th Sep 20165:44 pmRNSDirector/PDMR Shareholding
31st Aug 20161:37 pmRNSDirector/PDMR Shareholding
25th Aug 20165:24 pmRNSDirector/PDMR Shareholding
18th Aug 20164:00 pmRNSDirector/PDMR Shareholding
17th Aug 20165:59 pmRNSDirector/PDMR Shareholding
17th Aug 20165:58 pmRNSDirector/PDMR Shareholding
17th Aug 20165:49 pmRNSDirector/PDMR Shareholding
15th Aug 20165:00 pmRNSDirector/PDMR Shareholding
8th Aug 20162:28 pmRNSHolding(s) in Company
5th Aug 201611:03 amRNSNational Storage Mechanism filing
3rd Aug 20167:00 amRNSResult of AGM
2nd Aug 20167:00 amRNSTrading Statement
18th Jul 20166:23 pmRNSDirector/PDMR Shareholding
18th Jul 20166:22 pmRNSDirector/PDMR Shareholding
18th Jul 20166:22 pmRNSDirector/PDMR Shareholding
18th Jul 20166:21 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.